Association of Acute Kidney Injury and Chronic Kidney Disease With Concentration-To-Dose Ratios of Midazolam and Its Main Metabolites in Critically Ill Adults.

Shudofsky K, Abma J, Driessen J, Slikkerveer M, Vanmolkot F, Janssen P, le Noble J

Open source

DOI
10.1111/fcp.70108
Published
2026 Jul
Container
Fundamental & clinical pharmacology
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1111/fcp.70108,
  title = {Association of Acute Kidney Injury and Chronic Kidney Disease With Concentration-To-Dose Ratios of Midazolam and Its Main Metabolites in Critically Ill Adults.},
  author = {Shudofsky K and Abma J and Driessen J and Slikkerveer M and Vanmolkot F and Janssen P and le Noble J},
  year = {2026},
  journal = {Fundamental \& clinical pharmacology},
  doi = {10.1111/fcp.70108},
  url = {https://doi.org/10.1111/fcp.70108}
}

RIS

TY  - JOUR
TI  - Association of Acute Kidney Injury and Chronic Kidney Disease With Concentration-To-Dose Ratios of Midazolam and Its Main Metabolites in Critically Ill Adults.
AU  - Shudofsky K
AU  - Abma J
AU  - Driessen J
AU  - Slikkerveer M
AU  - Vanmolkot F
AU  - Janssen P
AU  - le Noble J
PY  - 2026
JO  - Fundamental & clinical pharmacology
DO  - 10.1111/fcp.70108
UR  - https://doi.org/10.1111/fcp.70108
ER  - 

APA

K, S., J, A., J, D., M, S., F, V., P, J., & J, L. N. (2026). Association of Acute Kidney Injury and Chronic Kidney Disease With Concentration-To-Dose Ratios of Midazolam and Its Main Metabolites in Critically Ill Adults.. Fundamental & clinical pharmacology. https://doi.org/10.1111/fcp.70108

Source records